The global peptide therapeutics market is growing significantly due to the increasing prevalence of cardiovascular diseases and cancer, advances in peptide therapeutics manufacturing technology, and increasing healthcare expenditure. In addition, growing research and development activities along with a rich peptide therapeutics pipeline is expected to support the growth of the peptide therapeutics market. Patent expiration of several peptide drugs in the coming years will create ample opportunities for the global generic peptide therapeutics market to grow at a significant rate in the forecasted period. Peptides are made up of short chains of amino acid monomers. Peptide therapeutics have applications in several indications such as cancer, central nervous system disorders, respiratory disorders, and cardiovascular diseases; this is due to high selectivity, efficacy and safety of peptides.
View Full Report with TOC @ http://www.acutemarketreports.com/report/peptide-therapeutics-market
The advanced research and development facilities and new peptide developments by the pharmaceutical companies are propelling the demand for cost effective peptide therapeutics. However, production of peptides in a large scale with the increasing complexities of peptides is a major challenge for the global peptide therapeutics market. Development of multifunctional peptides and increasing number of collaboration for the development of peptide conjugates are trends in the global peptide therapeutics market.
Peptide therapeutics market can be categorized on the basis of product types, mode of administration and therapeutic applications. Based on product types, the peptide therapeutics market can be categorized as generic peptides and branded peptides. On the basis of mode of administration, peptide therapeutics market can be segmented as oral mode of administration and parenteral mode of administration.
Browse All Reports of This Category @ http://www.acutemarketreports.com/category/healthcare-market
In addition, based on therapeutic applications, the market can be categorized as gastrointestinal disorders, infection, respiratory disorders, central nervous system, cardiovascular diseases, acromegaly, and cancer. Cancer leads the market due to increasing number of new cancer cases.
Some of the factors driving the growth of the global peptide therapeutics market are increasing prevalence of chronic diseases, increasing healthcare expenditure, and increasing investment by pharmaceutical companies for the development of peptide therapeutics. In addition, advancements in peptide manufacturing technology and rich peptide research and development pipeline are propelling the growth of the global peptide therapeutics market. However, stringent regulatory requirements for drug approval, high cost of peptide drugs, and chemical complexities and instability of peptides are some of the factors restraining the growth of the global peptide therapeutics market.
For More Information visit: Acute Market Reports
About Acute Market Reports
Acute Market Reports is the most sufficient collection of market intelligence services online. It is your only source that can fulfill all your market research requirements. Acute Market Reports provide online reports from over 100 best publishers and upgrade Acute Market Reports collection regularly to offer you direct online access to the world’s most comprehensive and recent database with expert perceptions on worldwide industries, products, establishments and trends. Acute Market Reports database consists of 200,000+ market research reports with detailed & minute market research.
Office No 01, 1st Floor,
Aditi Mall, Baner, Pune,
MH, 411045 India
Phone (India): +91 7755981103
Toll Free (US/Canada): +1-855-455-8662